Skip to main content

Microsoft Research, SIB, University of Geneva Start Bioinformatics Collaboration

NEW YORK (GenomeWeb News) – Microsoft Research will work with the Swiss Institute of Bioinformatics and the University of Geneva’s Proteome Informatics Group in a research collaboration that will combine mass spectrometry with an informatics platform aimed at screening human blood for toxic biomarkers, SIB said Friday.
 
Under the two-year agreement, Microsoft Research will fund the joint development and implementation of a combined software and database platform that can detect the effects of certain drug chemical fragments found in patients’ blood samples through mass spectrometry screening.
 
SIB said the Biomedical Proteomics Research Group and Geneva Bioinformatics, two of the Proteome Informatics Group’s partners, also will be involved in the collaboration. GeneBio is a private company founded in 1997 to commercialize SIB’s technology, and it also markets its own Phenyx proteomics software.
 
The collaboration will seek to identify conflicts between different drugs and eventually will attempt to develop technology that can predict how these conflicts may affect patients, particularly cancer patients.
 
“The multi-disciplinary expertise in medicine, proteomics and bioinformatics … will allow us to move faster in unraveling a currently major problem in prescribing drugs to patients,” SIB Executive Director Ron Appel said in a statement.
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.